AliveCor shrinks the ECG and speeds up diagnosis
AliveCor has launched the **Kardia 12L**, a handheld, AI-powered ECG device that brings hospital-grade heart monitoring directly to clinicians and patients acro...
significant
Every story
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2161–2184 of 3,535
Curve Biosciences advances AI blood diagnostics
**Curve Biosciences** is pioneering a transformative approach to chronic disease monitoring through its **AI-powered blood diagnostics**, which aim to detect or...
significant
Omada Health study boosts quality of GLP-1 weight loss
A recent **12-week study** by Omada Health highlights the importance of **digital support** in conjunction with GLP-1 medications for weight loss, revealing tha...
significant
It’s Springtime and the Rejuvenation Field Is Flourishing
**Lifespan Research Institute (LRI) has made significant strides in rejuvenation science, emphasizing the potential for substantial life extension through innov...
PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses
PridCor Therapeutics LLC has announced a pivotal acquisition of a global antiviral asset portfolio, positioning itself as a frontrunner in the development of tr...
IMAAVY® (nipocalimab)▼shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)
**Nipocalimab (IMAAVY®) has demonstrated sustained clinical improvements in adult patients with antibody-positive generalized myasthenia gravis (gMG) over a fol...
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
**Atrioventricular Interval Modulation Therapy (AVIM Therapy)** has demonstrated promising results in the **MODERATO II trial**, showing an immediate average re...
Longevity Day at NFC Summit Lisbon Announces Speaker Lineup
**Longevity Day at NFC Summit Lisbon** is set to debut on **June 4, 2026**, at the Unicorn Factory, bringing together a diverse array of professionals from the...
noteworthy
New Data Quantifies the "NASM Premium": Certified Professionals Earn 22% More Than Industry Peers
A recent study by the **National Academy of Sports Medicine (NASM)** has revealed a significant earnings disparity among personal trainers based on their certif...
Mother’s Day Gift Ideas for Moms: Experiential Gifts Like Cooking Together Trending in 2026
**Raddish Kids** has emerged as a frontrunner in the experiential gifting space, particularly for Mother's Day, with its innovative cooking subscription boxes d...
The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic
The **Center for Cancer and Blood Disorders (CCBD)** has initiated a groundbreaking program to deliver **chimeric antigen receptor (CAR) T-cell therapy** in Mar...
Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA
Lumina Therapy Alliance has expanded its network with the inclusion of Wise Mind Institute, led by Dr. Wes Pederson, enhancing mental health service accessibili...
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
InnoCare Pharma has reported a **44.5% increase in drug sales** for Q1 2026, reaching **RMB 450.5 million**, driven by the successful commercialization of its t...
Leading Kidney Organizations Unite on Capitol Hill for “Kidney Diseases: The Hidden Crisis in American Health Care” Congressional Briefing
Today, leading kidney health organizations, including the **American Kidney Fund (AKF)** and the **American Society of Nephrology (ASN)**, convened on Capitol H...
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)
Alpha Tau Medical Ltd. has received FDA approval for an Investigational Device Exemption (IDE) supplement to expand its multi-center pilot study, IMPACT, aimed...
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial
Alpha Tau Medical Ltd. has initiated the **ACAPELLA trial**, a European multicenter clinical study assessing the efficacy of **Alpha DaRT** (Diffusing Alpha-emi...
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
Connect Biopharma has announced that its Phase 2 Seabreeze STAT trials for **rademikibart**, a next-generation anti-IL-4Rα monoclonal antibody, will continue wi...
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
Dogwood Therapeutics has secured a global development and commercialization license for its antiviral candidates, **IMC-1** and **IMC-2**, from PRIDCor Therapeu...
NEW YORK PLASTIC SURGICAL GROUP ANNOUNCES OPENING OF HARRISON, NY LOCATION
New York Plastic Surgical Group (NYPS Group) has expanded its footprint with the opening of a new office in Harrison, NY, marking its 13th location in the New Y...
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
Royal Philips has launched the **Bridge Plus Occlusion Balloon**, a next-generation device aimed at controlling bleeding during rare but critical **superior ven...
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Ardelyx, Inc. has announced an upcoming poster presentation at the Digestive Disease Week Conference (DDW) on May 2-5, 2026, focusing on **patient characteristi...
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
**electroCore, Inc.** has announced its participation in the documentary **Hacking the Vagus Nerve**, produced by The Root Cause Project and The Vagus Nerve Soc...
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio
MBX Biosciences, Inc. has announced an upcoming **Obesity Day** event on May 11, 2026, aimed at updating stakeholders on its expanding portfolio of obesity ther...
Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
**Nano-X Imaging Ltd.** has expanded its U.S. distribution network through a partnership with **Radiology Oncology Systems** (ROS) to distribute its **Nanox.ARC...